Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval

Mohamed A. Kamal; Samit Ganguly; Ananth Kadambi; Patrick F. Smith

doi:10.1002/cpt.3357

Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval

Mohamed A. Kamal
, Samit Ganguly
, Ananth Kadambi
, Patrick F. Smith

Pharmacy

Regeneron Pharmaceuticals, Inc.
Certara

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	518-521
Number of pages	4
Journal	Clinical Pharmacology and Therapeutics
Volume	116
Issue number	3
DOIs	https://doi.org/10.1002/cpt.3357
State	Published - Sep 2024

Access to Document

10.1002/cpt.3357

Cite this

@article{43dc29727a0944b4a3985b153978acb3,

title = "Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval",

author = "Kamal, \{Mohamed A.\} and Samit Ganguly and Ananth Kadambi and Smith, \{Patrick F.\}",

year = "2024",

month = sep,

doi = "10.1002/cpt.3357",

language = "English",

volume = "116",

pages = "518--521",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Extended Model-Informed Drug Development

T2 - Beyond Clinical Trials and Regulatory Approval

AU - Kamal, Mohamed A.

AU - Ganguly, Samit

AU - Kadambi, Ananth

AU - Smith, Patrick F.

PY - 2024/9

Y1 - 2024/9

UR - https://www.scopus.com/pages/publications/85198614820

U2 - 10.1002/cpt.3357

DO - 10.1002/cpt.3357

M3 - Article

C2 - 39010652

AN - SCOPUS:85198614820

SN - 0009-9236

VL - 116

SP - 518

EP - 521

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 3

ER -

Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval

Access to Document

Other files and links

Fingerprint

Cite this